Structural brain MRI abnormalities in pediatric patients with migraine

Maria A Rocca1, Roberta Messina, Bruno Colombo

  • 1Division of Neuroscience, Neuroimaging Research Unit, Institute of Experimental Neurology, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina, 60, 20132, Milan, Italy.

Journal of Neurology
|December 6, 2013
PubMed

Insights

Pediatric migraine patients show gray matter (GM) atrophy in pain-processing areas and altered putamen volume. These early brain changes may indicate a unique migraine biomarker.

Area of Science:

  • Neuroimaging
  • Pediatric Neurology
  • Pain Medicine

Background:

  • Adult migraine studies reveal gray matter (GM) atrophy in pain-processing regions.
  • Pediatric migraine's neurobiological underpinnings, particularly GM and white matter (WM) changes, require further investigation.

Purpose of the Study:

  • To investigate regional GM and WM volumetric differences in pediatric episodic migraine patients.
  • To correlate these brain morphometric changes with clinical disease manifestations.

Main Methods:

  • Acquired 3.0 Tesla MRI scans (T2-weighted and 3D T1-weighted) from 12 pediatric migraine patients and 15 healthy controls.
  • Utilized voxel-based morphometry (VBM) to assess GM and WM volume differences (p < 0.05, FWE-corrected).

Main Results:

  • Pediatric migraine patients exhibited significant GM atrophy in frontal and temporal pain-processing regions.
  • Increased right putamen volume was observed in patients; this correlated negatively with disease duration.
  • The left fusiform gyrus showed varied volume changes based on migraine aura status.

Conclusions:

  • Pediatric migraine is associated with GM morphometric abnormalities, particularly in pain-processing networks.
  • These early-onset abnormalities, independent of clinical characteristics, may serve as a phenotypic biomarker for pediatric migraine.